e-Profile Login and ID Quick Search
NABP e-News: August 6, 2008
New and Improved NABP e-News Now Available by Subscription
With this issue, NABP unveils a sharp new look for its biweekly e-News publication. In addition to providing educational, regulatory, and Association news for the state boards of pharmacy, the new format includes useful links to NABP Web pages. Additionally, e-News is now available by free subscription to all interested parties. e-News made its debut in August 2006 to provide the boards with timely and relevant information regarding the practice of pharmacy. Since then, e-News has been reported to be a useful resource and has been widely requested by other individuals. In response, NABP is pleased to make e-News available for the asking. While the executive directors of the boards of pharmacy will be automatically subscribed to continue receiving e-News,others can subscribe simply by sending an e-mail to NABPnews@nabp.net with "Subscribe" in both the subject and the body of the e-mail.
NABP Reports 99% of Internet Drug Outlets Out of Compliance with Pharmacy Regulations
In its August 1, 2008 "Internet Drug Outlet Identification Program Progress Report for State and Federal Regulatory Bodies," NABP reports that 99% of the Internet drug outlets it has assessed thus far appear to be operating in conflict with state and federal laws or NABP patient safety and pharmacy practice standards. The report informs regulators that, as of June 22, NABP has reviewed and verified its assessment of 404 sites. Of those sites, 400 appear to be out of compliance with program criteria, thereby posing a significant risk to the public health. These sites have been listed as "not recommended" on the NABP Web site. Only four (1%) of those 404 sites have been found to be potentially legitimate, pending verification of licensure and other criteria. These findings underscore the importance of this project and other efforts to contain the Web-based distribution of prescription drugs within the appropriate legal and regulatory framework. More information is available under Internet Pharmacies on the NABP Web site.
DEA Final Rule Categorizes N-phenethyl-4-piperidone as List I Controlled Substance
Drug Enforcement Administration (DEA) has issued a final rule to control N-phenethyl-4-piperidone (NPP), a chemical precursor used in the illicit manufacture of fentanyl, as a List I chemical under the Controlled Substances Act. DEA reports that clandestine laboratories have been using this chemical to illicitly manufacture the Schedule II controlled substance fentanyl. The interim rule with request for comment was published in the Federal Register on April 23, 2007; however, no comments were received. This final rule finalizes the regulations without change, effective July 25, 2008. The final rule is published in the July 25 Federal Register (Docket No. DEA–299F) and is posted on the DEA Web site at www.deadiversion.usdoj.gov/fed_regs/rules/2008/fr0725.htm.
Two Additional Facilities Awarded VAWD Accreditation
NABP recently accredited two new facilities through its Verified-Accredited Wholesale Distributors® (VAWD®) program, bringing the total number of accredited facilities to 280 as of August 1, 2008. A full listing of VAWD facilities is available under Accreditation Programs on the NABP Web site.
- Exel Inc is a subsidiary corporation of Exel Inc of Westerville, OH, which is a subsidiary of the German company Deutsche-Post. Exel is a third party logistics provider for Novartis. The company received accreditation for its Mechanicsburg, PA facility at 300 Salem Church Road.
- Integrated Commercialization Solutions, Inc, dba ICS, is a wholly owned subsidiary of the publicly held corporation ASD Specialty Healthcare Inc. The company is a third party logistics supplier, and specializes in high cost pharmaceuticals and biologicals that require special handling and shipping. The company received accreditation for its Reno, NV facility.
